Relative selenium insufficiency is a risk factor for developing severe Graves’ orbitopathy: a case–control study

BACKGROUND/AIMS: Selenium (Se), an antioxidant agent, is effective in preventing mild Graves’ orbitopathy (GO) deterioration. However, the significant risk of low serum Se concentration for GO progression has not been identified. Here, we aimed to investigate the risk of relative Se insufficiency an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open Ophthalmol
Autors principals: Lumyongsatien, Mingkwan, Bhaktikamala, Unnkade, Thongtong, Pennung, Sintuwong, Sunisa, Nimitwongsakul, Ornvenus, Kanokkantapong, Jugchawin, Pongpirul, Krit
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2021
Matèries:
Orbit and Oculoplastics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8112433/
https://ncbi.nlm.nih.gov/pubmed/34041363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2021-000713
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars